A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD
Clinical trial NCT07762872 · RECRUITING
Trial details
- NCT number
- NCT07762872
- Sponsor
- Junwei Hao, MD
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-07-20
- Primary completion
- 2027-07-20
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.